Publication: 2471

Publication: 2471

Validating RNAseq-Signatures of Vorinostat (VOR) Sensitivity and Resistance in Patients with Newly Diagnosed Glioblastoma (GBM) Treated with VOR, Temozolomide and Radiation Therapy From Alliance N0874/ABTC-0902.

URL

Google Scholar

Citation:: J Clin Oncol vol 34 (suppl) abstr 2029

Meeting Instance:: ASCO 2016
Year:: 2016
Type:: Abstract
Sub type:: Poster Discussion
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: Yes

Parents:: None
Children:: 2578

Program:: OGC
Primary Committee:: Neuro-Onc
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882

Corr. Author:
Authors:: S. Keith Anderson C. Ryan Miller Jann N. Sarkaria Kurt A. Jaeckle Jan C. Buckner Keith L. Ligon Karla V. Ballman Dennis F. Moore Jr. Manmeet S. Ahluwalia Eudocia Quant Lee Elise Hovarth Elizabeth Gerstner Glenn J. Lesser Michael Prados Stuart A. Grossman Caterina Giannini Patrick Y. Wen Evanthia Galanis

Networks:: CA011, CA824, GEISINGER, KS055, LAPS-MA036, LAPS-MN026, LAPS-NC007, NC002

Study: NCCTG-N0874
Multiple Studies, or Legacy Studies in Alliance Study:: ABTC-0902
Phases:: 1/2, 1/2

Keywords: